Vaxart, Inc. (VXRT): Depreciation & Amortization
$8.58M
Year ended 2025-12-31
$6.00M
Trailing 12 months to 2026-06-30
+13.9%
3-year compound annual growth
+25.9%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.58M | -3.1% | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | $8.85M | +2.6% | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | $8.62M | +48.6% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $5.80M | +38.0% | 2024-03-14, From 2022-01-01 |
| 2021-12-31 | $4.21M | +55.3% | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $2.71M | -24.6% | 2022-02-24, From 2020-01-01 |
| 2019-12-31 | $3.60M | +12.3% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $3.20M | +742.9% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $380.0K | n/a | 2019-02-06, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Vaxart, Inc. (VXRT) | 2025-12-31 | $8.58M | -3.1% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $35.94M | -4.4% |
| Vericel Corp (VCEL) | 2025-12-31 | $11.54M | +109.7% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $16.00M | -8.3% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $15.62M | -3.7% |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 2025-12-31 | $58.99M | -6.4% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $24.85M | -20.9% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $3.10M | -26.2% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $22.29M | +1.7% |
Compare VXRT, IOVA, VCEL, ADPT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗